According to Michael Belkin, an investment analyst who has gained a glowing reputation, the stock-market rally is destined to take a plunge. He describes his long and short strategies for the coming months.
MSN.com October 22, 2003
Michael Belkin is a financial analyst whose daughter died a number of years ago from hepatitis B vaccine. Because of his prominence he has been able to testify before Congress on this issue.
Michael has been a valuable resource to me, exposing me to loads of health information. Although the story below has nothing to do with health, I thought some of you might be interested in what Michael does to earn his living and might actually benefit from his future financial projections. Now, I just have to figure out how I can charge $36,000 a year for my newsletter like Michael does (just kidding -- mine is and will remain free!).
Related Articles:
Financial Burdens Add to Stress of Terminal
© Copyright 2008 Dr. Joseph Mercola. All Rights Reserved. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format. If possible, I would also appreciate an endorsement and encouragement to subscribe to the newsletter. If any other use is desired, permission in writing from Dr. Mercola is required. Manufactured from 100% recycled electrons.
Disclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Mercola and his community. Dr. Mercola encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.
